An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on November 5, 2010 |
| Author/s |
author: Bradley J. Monk |
| Publication date | November 5, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://api.elsevier.com/content/article/PII:S0090825810007560?httpAccept=text/xml |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |